Galera Therapeutics shares are trading lower after the company announced it will be delisted by Nasdaq.
Portfolio Pulse from Benzinga Newsdesk
Galera Therapeutics shares are trading lower after the company announced it will be delisted by Nasdaq.
June 03, 2024 | 3:16 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Galera Therapeutics shares are experiencing a decline following the announcement of its delisting from Nasdaq. This news is likely to cause further downward pressure on the stock in the short term.
The delisting from Nasdaq is a significant negative event for Galera Therapeutics, leading to reduced investor confidence and liquidity. This is expected to result in further short-term declines in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100